<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04245098</url>
  </required_header>
  <id_info>
    <org_study_id>CSPT_AMICAR1</org_study_id>
    <nct_id>NCT04245098</nct_id>
  </id_info>
  <brief_title>Carpal Tunnel Syndrome and Amyloidosis</brief_title>
  <acronym>AMICAR</acronym>
  <official_title>Carpal Tunnel Syndrome and Amyloidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Carpal tunnel syndrome has been suggested to be an early sign of amyloidosi. The
      investigators will evaluate tissue samples obtained from patients undergoing carpal tunnel
      release surgery for amyloid.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carpal tunnel syndrome (CTS) can be caused by the deposition and accumulation of misfolded
      proteins called amyloid and is often an early manifestation of systemic amyloidosis.

      Patients with cardiac amyloidosis often have carpal tunnel syndrome that precedes cardiac
      manifestations by several years, and many patients will have undergone surgery for idiopathic
      carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of
      the hand.

      The investigators sought to identify the prevalence and type of amyloid deposits in patients
      undergoing carpal tunnel surgery and evaluate for cardiac involvement
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2020</start_date>
  <completion_date type="Anticipated">January 8, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 8, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with amyloid deposits in patients undergoing carpal tunnel surgery</measure>
    <time_frame>2 years</time_frame>
    <description>Prevalence of amyloid deposits in biopsy in patients undergoing carpal tunnel syndrome surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with cardiac involvement in echocardiogram</measure>
    <time_frame>2 years</time_frame>
    <description>Cardiac involment in echocardiography</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Amyloidosis</condition>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>Amyloid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carpal tunnel syndrome surgery</intervention_name>
    <description>Biopsy</description>
    <arm_group_label>Amyloid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing carpal tunnel syndrome surgery

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria del Carmen Navarro-Saez, M.D.</last_name>
    <phone>937 231 010</phone>
    <phone_ext>21990</phone_ext>
    <email>mnavarros@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maria Del Carmen Navarro-Saez</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria del Carmen Navarro-Saez, M.D.</last_name>
      <phone>937 231 010</phone>
      <phone_ext>21990</phone_ext>
      <email>mnavarros@tauli.cat</email>
    </contact>
    <investigator>
      <last_name>Carlos Feijoo-Mass√≥, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre Berenguer-Sanchez, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Maria del Carmen Navarro-Saez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>carpal tunnel syndrome</keyword>
  <keyword>amyloidosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

